Ilan Merdler (@IlanMerdler) header
Ilan Merdler (@IlanMerdler) profile picture

MD, MHA, FACC | Assistant Professor of Medicine | Fixing hearts by day (and sometimes at night) 🫀 | Dad to Libi & Nadav 👧👶 | Coffee-powered ☕

New York, NY
Joined October 2023
Ilan Merdler retweeted
In this review will seek to highlight prior studies and future directions in the treatment of acute coronary syndrome in patients with rheumatologic disease. Great work by @IlanMerdler @andrew_p_hill @GTCardFellows @MedStarHealth
1
7
774
Ilan Merdler retweeted
11
17
1,622
Ilan Merdler retweeted
Published #JACCINT our global survey understanding the perspective of IC in regards to CFT. Overcoming misconceived barriers and performing uniform testing is still needed. @IlanMerdler @KalChitturi @ron_waksman @HashimHayder @JACCJournals @CRT_meeting doi.org/10.1016/j.jcin.2024.…
4
9
25
2,018
Does epicardial fat play a role in coronary microvascular dysfunction (CMD)? 🤔Our new study suggests a link between increased epicardial fat index and CMD. More studies needed, but our research could be a key to better CMD diagnosis & treatment! doi.org/10.1161/JAHA.124.038… #cardiology #CMD #CardioTwitter #MustRead @ACCinTouch @GTCardFellows @BCaseMD1 @KalChitturi @IAmDoctorAbhi @lior_lupu @haberdan @HashimHayder @DorBen @MedStarWHC @JAHA_AHA
2
7
2
17
2,851
Ilan Merdler retweeted
PROTECT IV is enrolling high-risk PCI with or without Impella with a sample size estimate of 1252 patients. Our center's 2-year outcome is 30.8 %, we estimate that PROTECT IV requires 1966 patients, demonstrating that PROTECT IV is probably underpowered. pubmed.ncbi.nlm.nih.gov/3901…
2
10
24
2,332
Just accepted in @CRMjournal+@ELS_Cardiology! Impact of #LBBBor permanent #PPM after #TAVR #TAVI on mid-term #LVEF by @IlanMerdler @BCase07 @KalChitturi @DorBen @ronwaksman et al. clinicalkey.com/#!/content/p…
6
5
835
The 2nd episode of “The Fellows’ Call” is now out, where we discuss the need for an abbreviated duration and more efficient pathways of training in medicine subspecialities ✨ Check out the link 👉🏻 rb.gy/u5the6 & let us know what you think! #CardioTwitter #ACCFIT
4
18
1,431
Just published in @CircIntv: Our State-of-the-Art Review on Bioprosthetic #Aortic #Valve Thrombosis, in which we discuss the incidence, mechanisms, diagnosis, and management of subclinical and clinical leaflet #thrombosis. bit.ly/4bSGDlg #cardiotwitter #YesCCT #TAVR
3
9
1
53
4,611
Just published in @CRMjournal Interesting Cases! We describe primary closure of the aorto-caval tract after #transcaval #TAVR with a covered stent in a small sized abdominal aorta. bit.ly/3ypOyYo @IlanMerdler @lior_lupu @BCase07 @ron_waksman @DorBen #TobyRogers
2
19
963
From Chest Pain to #Coronary Function Testing: Clinical and Economic Impact of Coronary Microvascular Dysfunction #CMD with @BCase07 and @IlanMerdler crtonline.org/video-detail/f…
7
1
9
4,144
Just accepted in @CRMjournal+@ELS_Cardiology! Unveiling the value of left ventriculography in #STEMI by @IlanMerdler @BCase07 @DorBen @ron_waksman et al. clinicalkey.com/#!/content/p…
4
1
9
3,046
Ilan Merdler retweeted
Our State of the Art Review in @EuroInterventio discussing inflammation in atherosclerosis, biomarkers, therapeutic options (strengths/limitations) future advancements, and notable clinical studies. Also, an algorithm for residual inflammatory risk (RIR). eurointervention.pcronline.c…
1
7
1
17
3,635
Drs. @BCaseMD1, @ron_waksman, et al. sought to identify racial and ethnic disparities in the enrollment of minority patients into CV clinical trials at a large tertiary urban research health care center: bit.ly/3MCavb4 #JACCINT #HealthDisparities #ClinicalTrials
5
5
4,125